Alliance for Multispecialty Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gout2 trials
• COPD1 trial

Phase

• Phase 2/32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Atom Therapeutics Co., Ltd2 trials
• Uniquity One (UNI)1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

Closed trials

• Terminated

  Extension Study of ABP-671 in Participants With Gout

  NCT06276556· Phase 2/3· Atom Therapeutics Co., Ltd· Source

• Completed

  Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

  NCT05818085· Phase 2/3· Atom Therapeutics Co., Ltd· Source